I think you're confusing Samsung Biologics with Samsung Bioepis. Samsung Biologics is a division of Samsung which is a contract manufacturer to just about anybody. They are now the 3rd largest contractor behing Boehringer and Lonza.
Samsung Bioepis is a seperate company wholly owned by Samsung (90%) and Biogen (10%). This is not to say the Sansung Biologics couldn't be a subcontractor to Samsung Bioepis which has its main mfg plant in Incheon Korea.
Bioepis plans a IPO soon. The thought is it is a $7 to $8 Bil Company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.